Carthera
A clinical-stage medtech company focused on developing innovative ultrasound-based medical devices to treat a wide range of severe brain disorders. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€188m (Public information from Dec 2023)
Company register number 520004607
Lyon Auvergne-Rhône-Alpes (HQ)
Financials
Estimates*
| EUR | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 |
|---|---|---|---|---|---|---|---|
| Revenues | - | - | <1m | <1m | <1m | <1m | <1m |
| % growth | - | - | - | 42 % | 136 % | (78 %) | 1526 % |
| EBITDA | (<1m) | (1.3m) | (1.9m) | (3.1m) | (3.4m) | (3.1m) | - |
| % EBITDA margin | - | - | (32583 %) | (37472 %) | (17370 %) | (69995 %) | - |
| Profit | (<1m) | (1.1m) | (1.7m) | (2.8m) | (3.0m) | (2.1m) | (1.5m) |
| % profit margin | - | - | (29479 %) | (33578 %) | (15491 %) | (48780 %) | (2132 %) |
Source: Dealroom estimates
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
N/A | Support Program | ||
| N/A | €2.1m | Series A | |
* | €5.7m | Grant | |
* | €10.0m | Series B | |
N/A | Grant | ||
* | €2.1m | Grant | |
* | €10.5m | Early VC | |
* | €37.5m | Series B | |
* | €4.5m Valuation: €188m | Series B | |
| Total Funding | €72.4m | ||
Related Content
Recent News about Carthera
EditMore about Carthera
EditOperator of a clinical-stage medtech company intended to develop ultrasound-based medical devices designed to treat brain disorders. The company's devices are intracranial ultrasound implant that temporarily opens the blood-brain barrier and makes way for a significantly increased concentration of therapeutic molecules to reach the brain, enabling doctors and medical professionals with therapeutic devices to diagnose and treat brain complications.
Keywords: Healthcare Devices, Services, Supplies, Brain Imaging, Medical Device, Medical Devices Provider, Neurosurgery Device, Neurosurgery Tools, Neurosurgical Tools.
Tech stack
Tech stackLearn more about the technologies and tools that this company uses.